Eric Venker

President & Immunovant CEO, Roivant Sciences; Chief Executive Officer, Director, Immunovant, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$77.4M

Companies

Latest trade

Oct 20, 2026

Companies

Roivant SciencesPresident & Immunovant CEO −$104M Immunovant, Inc.Chief Executive Officer, Director −$0.6M

Trades

ROIV Sold 200,000 shares at $35.11 · planned $7.0M Oct 20

IMVT Sold 3,506 shares at $34.11 $0.1M Oct 2

ROIV Sold 200,000 shares at $36.62 · planned $7.3M Sep 30

ROIV Sold 200,000 shares at $35.77 · planned $7.2M Aug 28

ROIV Sold 200,000 shares at $34.95 · planned $7.0M Jul 27

IMVT Sold 3,092 shares at $38.48 $0.1M Jul 2

ROIV Sold 200,000 shares at $33.16 · planned $6.6M Jun 24

ROIV Sold 200,000 shares at $30.27 · planned $6.1M May 22

ROIV Sold 200,000 shares at $29.59 · planned $5.9M Apr 20

IMVT Sold 14,229 shares at $24.10 $0.3M Apr 2

ROIV Sold 200,000 shares at $28.24 · planned $5.6M Mar 17

ROIV Sold 200,000 shares at $26.49 · planned $5.3M Feb 13

ROIV Sold 200,000 shares at $21.92 · planned $4.4M Jan 12

ROIV Sold 75,000 shares at $22.53 $1.7M Dec 24

ROIV Sold 200,000 shares at $22.45 $4.5M Dec 23

ROIV Sold 200,000 shares at $20.85 · planned $4.2M Dec 9

ROIV Sold 200,000 shares at $20.22 · planned $4.0M Nov 7

ROIV Sold 118,418 shares at $17.06 · planned $2.0M Oct 17

ROIV Sold 318,282 shares at $17.05 · planned $5.4M Oct 16

ROIV Sold 414,683 shares at $16.93 · planned $7.0M Oct 15

ROIV Sold 20,727 shares at $16.25 · planned $0.3M Oct 13

ROIV Sold 104,940 shares at $16.30 · planned $1.7M Oct 9

ROIV Sold 138,602 shares at $16.20 · planned $2.2M Oct 8

ROIV Sold 355,161 shares at $16.15 · planned $5.7M Oct 7

ROIV Sold 171,396 shares at $16.34 · planned $2.8M Oct 6

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.